Encompass Health Corp（EHC）股票分析EHCEncompass Health Corp

Encompass Health Corporation is a provider of inpatient rehabilitation services. The Company provides specialized rehabilitative treatment, using technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability. It operates hospitals in approximately 39 states and Puerto Rico, with concentrations in Florida and Texas. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver patient care services. It offers neurological, spinal & brain-related rehabilitation, which include brain injury rehabilitation, multiple trauma rehabilitation, neurological rehabilitation, spasticity management, spinal cord injury rehabilitation and stroke rehabilitation. It also offers orthopedic & joint-related rehabilitation, which includes amputee rehabilitation, chronic condition management, hip rehabilitation and orthopedic rehabilitation. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Encompass Health Corp (EHC) is a good buy right now, trading at $124.09, which is below the analyst price target of $150, suggesting a potential upside of 21%. The company has a solid gross margin of 90.20% and a forward P/E of 19.01, indicating strong profitability and growth prospects. However, the main risk is the recent insider selling, with executives selling shares at an average price of $125.95, which could signal caution among some investors.